Medidata Appoints Dr. Maria Rivas to its Board of Directors
October 22 2018 - 5:30PM
Business Wire
Appointment is initial step toward company
pledge to 2020 Women on Boards initiative
Medidata (NASDAQ: MDSO) announced today that it has appointed
Dr. Maria Rivas to its Board of Directors. An endocrinologist with
extensive experience as a senior leader in the pharmaceutical
industry, Dr. Rivas becomes the first woman to serve on the
company’s board. This also marks her first public board
appointment.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20181022005900/en/
Dr. Maria Rivas (Photo: Business
Wire)
“We are thrilled that Maria has joined our board,” said Tarek
Sherif, chairman and chief executive officer, Medidata. “She has
deep experience as an executive leader, as well as an extensive
background in research and health outcomes. We look forward to
working with her, as we continue to lead digital transformation
within life sciences.”
“It’s an honor to join the board of a company that continues to
deliver innovative solutions which are transforming the industry,”
said Dr. Rivas. “I look forward to working with the board and
executive management to help Medidata succeed in its mission to
power smarter treatments and healthier people.”
Dr. Rivas is the first board appointee as part of Medidata’s
fulfillment of its 2020 Women on Boards initiative pledge which
aims to have 20% female membership by 2020. Medidata was committed
to finding a female candidate from an underrepresented population
to serve on a public company board for the first time.
In her career, Dr. Rivas has built and led global teams of 2,000
medical, research, safety, communications, and compliance
professionals in over 90 countries to deliver market insights and
enrich product value propositions, improve healthcare, and enhance
company reputation. She launched new products in multiple
therapeutic areas including Oncology and Immunology. Dr. Rivas
worked in US and international settings, including tertiary
teaching hospitals and private practice.
For close to two decades, Dr Rivas served as a senior executive
in S&P 500 companies and is currently the Senior Vice
President, Head of Global Medical Affairs at the biopharma business
of Merck KGaA, Darmstadt, Germany, which operates as EMD Serono in
the U.S. and Canada.
About Medidata
Medidata is leading the digital transformation of life sciences,
with the world's most used platform for clinical development,
commercial, and real-world data. Powered by artificial intelligence
and delivered by the #1 ranked industry experts, the Intelligent
Platform for Life Sciences helps pharmaceutical, biotech, medical
device companies, and academic researchers accelerate value,
minimize risk and optimize outcomes. Medidata serves more than
1,000 customers and partners worldwide and empowers more than
100,000 certified users everyday to create hope for millions of
patients. Discover the future of life sciences: www.mdsol.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20181022005900/en/
Medidata Solutions:Investors:Betsy Frank,
917-522-4620bfrank@mdsol.comorMedia:Erik Snider,
646-362-2997esnider@mdsol.com
Medidata Solutions (NASDAQ:MDSO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Medidata Solutions (NASDAQ:MDSO)
Historical Stock Chart
From Apr 2023 to Apr 2024